# Sightlife – FDA Inspection, Dec 17, 2012

Source: https://www.keypedia.com/records/fda_inspections/sightlife/34ae8cd2-dd58-4172-805b-5477604dc6fb
Source feed: FDA_Inspections

> FDA inspection 811110 of Sightlife, December 17, 2012. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 811110
- Company Name: Sightlife
- Inspection Date: 2012-12-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1318978 - 2026-04-30
- FDA Inspection 1254770 - 2024-11-18
- FDA Inspection 1198187 - 2023-02-10
- [FDA Inspection 1028861 - 2017-10-13](https://www.keypedia.com/records/fda_inspections/sightlife/b7c48c7a-0299-4259-84d9-154fc5f94dd2)
- [FDA Inspection 963070 - 2016-03-14](https://www.keypedia.com/records/fda_inspections/sightlife/d14e380d-3687-41e2-a386-46cfee6b16d9)

Company: https://www.keypedia.com/companies/sightlife/7bfeee4c-fe3f-4f4d-8837-5845b36d913c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d